Vascular Access in Dialysis | Fistula First, Catheter Last

🩸 Vascular Access in Dialysis Patients
Fistula First, Catheter Last

The type of vascular access is one of the strongest predictors of survival, infection risk, and quality of life on hemodialysis. Arteriovenous fistula (AVF) is the gold standard. Central venous catheters (CVC) are associated with higher mortality, more infections, and chronic inflammation.

📢 AV Fistula > AV Graft > Tunneled Catheter > Non-tunneled Catheter
Catheters should be the LAST resort, not the default.
⚠️ Why access type matters:
• Catheters have 2-3x higher infection risk compared to fistulas
• Catheters cause chronic inflammation (elevated CRP, ferritin) – harming anemia and nutrition
• Catheters are associated with higher mortality – up to 50% higher in first year
• Catheters have higher failure rates (thrombosis, stenosis, malfunction)
• Fistulas provide better dialysis adequacy (Kt/V) and lower recirculation
✅ Our unit's goal: Increase fistula prevalence, reduce catheter use. Every patient without a permanent access should be evaluated for fistula creation immediately. Catheters are a bridge, not a destination.
🆘 The hidden cost of catheters – inflammation:
Catheters create a continuous low-grade inflammatory state due to biofilm, recurrent subclinical infections, and endothelial injury. This drives:
Erythropoietin resistance (more anemia, more EPO needed)
Hypoalbuminemia (malnutrition/inflammation complex)
Higher ferritin (functional iron deficiency – iron trapped in stores)
Cardiovascular events (inflammation accelerates atherosclerosis)

Converting a catheter to a fistula is not just about infection – it reduces systemic inflammation and improves overall outcomes.
🏥 Practical recommendations for our dialysis unit
  1. Every incident patient should be referred for fistula creation at least 6-12 months before starting dialysis.
  2. Catheters should be removed as soon as a functional fistula is ready (typically 2-4 weeks after maturation).
  3. For patients with a catheter: Monitor CRP, ferritin, and albumin closely – these predict complications.
  4. Track access types monthly and aim for fistula prevalence >60-80% in prevalent patients.
  5. Educate patients: Fistula surgery is a one-time investment that pays back with fewer infections, better dialysis, and longer life.

🎯 Final conclusion

"Fistula First" is not a slogan – it is evidence-based medicine. Our own data (below) will likely show that patients with fistulas have lower ferritin, better hemoglobin, fewer hospitalizations, and longer survival compared to catheter-dependent patients.

Call to action: Review every catheter patient in our unit. Ask: "Why does this patient still have a catheter?" If there is no anatomical barrier, create a plan for fistula placement within 3 months.